California Cancer Associates for Research & Excellence, Inc. (Encinitas)
Encinitas, CA
Accepting patients
Ruxolitinib
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
- Kinase Inhibitor
- Phase 1
- Has results